268 related articles for article (PubMed ID: 19351405)
1. Concurrent chemoradiotherapy in adjuvant treatment of breast cancer.
Ismaili N; Mellas N; Masbah O; Elmajjaoui S; Arifi S; Bekkouch I; Ahid S; Bazid Z; Tazi MA; Erraki A; El Mesbahi O; Benjaafar N; El Gueddari Bel K; Ismaili M; Afqir S; Errihani H
Radiat Oncol; 2009 Apr; 4():12. PubMed ID: 19351405
[TBL] [Abstract][Full Text] [Related]
2. Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
Kim K; Chie EK; Han W; Noh DY; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Tumori; 2011; 97(3):280-5. PubMed ID: 21789003
[TBL] [Abstract][Full Text] [Related]
3. Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
Fernando IN; Bowden SJ; Herring K; Brookes CL; Ahmed I; Marshall A; Grieve R; Churn M; Spooner D; Latief TN; Agrawal RK; Brunt AM; Stevens A; Goodman A; Canney P; Bishop J; Ritchie D; Dunn J; Poole CJ; Rea DW;
Radiother Oncol; 2020 Jan; 142():52-61. PubMed ID: 31785830
[TBL] [Abstract][Full Text] [Related]
4. Concomitant adjuvant chemo-radiation therapy with anthracycline-based regimens in breast cancer: a single centre experience.
Livi L; Meattini I; Scotti V; Saieva C; Simontacchi G; Marrazzo L; Franzese C; Cassani S; Paiar F; Di Cataldo V; Nori J; Jose Sanchez L; Bianchi S; Cataliotti L; Biti G
Radiol Med; 2011 Oct; 116(7):1050-8. PubMed ID: 21424317
[TBL] [Abstract][Full Text] [Related]
5. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
Isaac N; Panzarella T; Lau A; Mayers C; Kirkbride P; Tannock IF; Vallis KA
Cancer; 2002 Aug; 95(4):696-703. PubMed ID: 12209711
[TBL] [Abstract][Full Text] [Related]
6. Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancer.
Montemurro F; Gatti M; Redana S; Jacomuzzi ME; Nanni D; Durando A; Popolo M; Ponzone R; Rossi A; Albieri V; Valabrega G; Sismondi P; Gabriele P; Aglietta M
J Chemother; 2006 Feb; 18(1):90-7. PubMed ID: 16572899
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline and concurrent radiotherapy as adjuvant treatment of operable breast cancer: a retrospective cohort study in a single institution.
Ismaili N; Elmajjaoui S; Lalya I; Boulaamane L; Belbaraka R; Abahssain H; Aassab R; Benjaafar N; El Guddari Bel K; El Mesbahi O; Sbitti Y; Ismaili M; Errihani H
BMC Res Notes; 2010 Oct; 3():247. PubMed ID: 20920323
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Francis P; Crown J; Di Leo A; Buyse M; Balil A; Andersson M; Nordenskjöld B; Lang I; Jakesz R; Vorobiof D; Gutiérrez J; van Hazel G; Dolci S; Jamin S; Bendahmane B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Piccart-Gebhart M;
J Natl Cancer Inst; 2008 Jan; 100(2):121-33. PubMed ID: 18182617
[TBL] [Abstract][Full Text] [Related]
9. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study.
Fiets WE; van Helvoirt RP; Nortier JW; van der Tweel I; Struikmans H
Eur J Cancer; 2003 May; 39(8):1081-8. PubMed ID: 12736107
[TBL] [Abstract][Full Text] [Related]
10. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
[TBL] [Abstract][Full Text] [Related]
11. Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery.
Faul C; Brufsky A; Gerszten K; Flickinger J; Kunschner A; Jacob H; Vogel V
Eur J Cancer; 2003 Apr; 39(6):763-8. PubMed ID: 12651201
[TBL] [Abstract][Full Text] [Related]
12. Postmastectomy radiotherapy and concomitant adjuvant chemotherapy versus adjuvant chemotherapy alone in premenopausal breast cancer patients with positive axillary nodes.
Micheletti E; La Face B; Huscher A; Catalano G; Ambrosi E; Marini G; Simoncini E
Tumori; 1998; 84(6):652-8. PubMed ID: 10080670
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer.
Lamb D; Atkinson C; Joseph D; O'Brien P; Ackland S; Bonaventura A; Dady P; Hamilton C; Spry N; Stewart J; Denham J
Australas Radiol; 1999 May; 43(2):220-6. PubMed ID: 10901906
[TBL] [Abstract][Full Text] [Related]
14. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
[TBL] [Abstract][Full Text] [Related]
15. Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients.
Ploner F; Jakesz R; Hausmaninger H; Kolb R; Stierer M; Fridrik M; Steindorfer P; Gnant M; Haider K; Mlineritsch B; Tschurtschenthaler G; Steger G; Seifert M; Kubista E; Samonigg H;
Onkologie; 2003 Apr; 26(2):115-9. PubMed ID: 12771518
[TBL] [Abstract][Full Text] [Related]
16. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.
Livi L; Saieva C; Borghesi S; Paoletti L; Meattini I; Rampini A; Petrucci A; Scoccianti S; Paiar F; Cataliotti L; Leonulli BG; Bianchi S; Biti GP
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):705-9. PubMed ID: 18191333
[TBL] [Abstract][Full Text] [Related]
17. Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer.
Valagussa P; Moliterni A; Terenziani M; Zambetti M; Bonadonna G
Ann Oncol; 1994 Nov; 5(9):803-8. PubMed ID: 7848882
[TBL] [Abstract][Full Text] [Related]
18. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
Wallgren A; Bernier J; Gelber RD; Goldhirsch A; Roncadin M; Joseph D; Castiglione-Gertsch M
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):649-59. PubMed ID: 8690630
[TBL] [Abstract][Full Text] [Related]
19. Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients.
Bernard-Marty C; Mano M; Paesmans M; Accettura C; Munoz-Bermeo R; Richard T; Kleiber K; Cardoso F; Lobelle JP; Larsimont D; Piccart MJ; Di Leo A
Ann Oncol; 2003 May; 14(5):693-8. PubMed ID: 12702521
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant sequential chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil (ACMF) with concurrent radiotherapy in resectable advanced breast cancer.
Hsieh CI; Liu MC; Cheng SH; Liu TW; Chen CM; Chen CM; Tsou MH; Huang AT
Am J Clin Oncol; 2000 Apr; 23(2):122-7. PubMed ID: 10776970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
